• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Chromatin

edit

Chromatin is a biotech company developing and marketing innovative technologies and products that benefit the agricultural, energy, chemical, nutritional, and pharmaceutical sectors. Chromatin is unlocking the potential of plants to produce greater value and meaningful products for consumers, growers, seed producers, and bioprocessors. Chromatin is commercializing solutions which proactively address key societal challenges such as improving agricultural productivity and increasing renewable energy resources.

Milestones

edit

• 
  Chromatin received $10M in Series D funding. (10/25/11)
  Posted 10/25/11 at 7:06pm via finsmes.com
• 
  Chromatin received $1.6M in Venture Round funding. (4/1/06)
  Posted 4/29/10 at 4:11am
• 
  Chromatin — Chromatin Receives $5.7M Award from Department of Energy (1/6/12)
  Posted 1/7/12 at 12:02am via finsmes.com

Videos

Screenshots

edit

Above: Chromatin
Uploaded: 4/29/10

Sources

1. Cap Funding Report [edit]
2. Chromatin Completes $10M First Closing of Series D Financing (finsmes.com) [edit]
Chromatin Receives $5.7M Award from Department of Energy (finsmes.com) [edit]